INTERPACE BIOSCIENCES, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Interpace Biosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
  • Interpace Biosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $38.7M, a 1.04% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $38.7M +$398K +1.04% Dec 31, 2023 10-K 2024-04-01
Q4 2022 $38.3M +$5.09M +15.3% Dec 31, 2022 10-K 2024-04-01
Q4 2021 $33.2M +$9.49M +40.1% Dec 31, 2021 10-K 2023-03-27
Q4 2020 $23.7M +$6.66M +39.1% Dec 31, 2020 10-K 2022-03-31
Q4 2019 $17M -$26.5M -60.9% Dec 31, 2019 10-K 2021-04-01
Q4 2018 $43.6M +$1.4M +3.33% Dec 31, 2018 10-K 2019-03-21
Q4 2017 $42.2M Dec 31, 2017 10-K 2019-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.